Protein Assays Market By Product Type (Kits and Reagents, Instruments and Accessories), By Technology (Absorbance Based Protein Assays, Colorimetric based protein assay, Fluorescence-Based Protein Assays), By Application (Drug Discovery and Development, Disease Diagnosis), By End User (Pharmaceutical and biotechnology companies, Clinical Laboratories, Others): Global Opportunity Analysis and Industry Forecast, 2023-2032
The protein assay market was valued at $2,377.93 million in 2022 and is estimated to reach $4,449.02 million by 2032, exhibiting a CAGR of 6.5% from 2023 to 2032.
The purpose of protein assay is to determine the amount or concentration of a specific protein or an array of different proteins in a sample. Isolating and detecting protein is used for many clinical and research processes. This can be a primary step before further manipulation in a research and development process, an initial capture of protein before structural analysis, or it can be a final detection step in a clinical laboratory as part of a disease diagnosis.
The determination of protein concentrations provides information about the necessity of corresponding intermediate steps. Protein quantitation could either be required for the total protein content of a sample, or for purified subsets thereof, such as affinity column fractions. There are various methods for protein assays such as dye binding protein assays (Bradford), protein assays based on copper ions (Lowry), or a novel test strip and spot application assay.
Major factors that drive the growth of the global protein assays market include rise in prevalence of chronic disease, upsurge in demand for personalized medicine, and critical role of protein assay method in drug discovery and development. Furthermore, increase in R&D investment in pharmaceutical & biotechnology industries for the development of technologically advanced protein assay kits and reagents and instruments and increase in the number of research activities in the field of proteomics are the major factors that increase the demand for protein assays tests kits and instruments and hence propel the growth of the market. In addition, increase in number of key market players and strategies they adopt for the development of technologically advanced protein assays products are the major factors that boost the growth of the protein assays market. For instance, in May 2023, 10x Genomics, Inc. a leader in single cell and spatial biology, announced the commercial availability of a new Visium CytAssist gene and protein expression product to expand the breadth of the Visium CytAssist spatial analysis capabilities. Visium CytAssist gene and protein expression enables researchers to simultaneously produce highly multiplexed protein and whole transcriptome RNA data mapped together from the same formalin-fixed, paraffin-embedded (FFPE) tissue section at high spatial resolution.
However, the lack of skilled workers and prohibitive cost associated with protein assay restrain the growth of the protein assays market. On the contrary, surge in demand for personalized medicine and expansion in the use of drug proteins are expected to provide lucrative opportunities for the growth of the protein assays market during the forecast period.
The protein assays market is segmented into product type, technology, application, end user, and region. Based on product type, the market is bifurcated into kits & reagents and instruments and accessories. Based on technology, it is divided into absorbance-based protein assay, colorimetric based protein assay and fluorescence-based protein assays. Based on application, it is classified into drug discovery and development and disease diagnosis. Based on end user, it is divided into pharmaceutical and biotechnology companies, clinical laboratories, and others. On the basis of region, it is analyzed across North America (the U.S., Canada, and Mexico), Europe (Germany, France, the UK, Italy, Spain, and rest of Europe), Asia-Pacific (China, Japan, Australia, India, South Korea, and rest of Asia-Pacific), and LAMEA (Brazil, South Africa, Saudi Arabia, and rest of LAMEA).
The major players profiled in the report are Sartorius AG, Agilent Technologies, Inc., Thermo Fisher Scientific Inc., Perkin Elmer Inc., Meril Life Sciences Pvt. Ltd., Abcam PLC, Cell Signaling Technology, Merck KGaA, Bio-Rad Laboratories Inc, and Bio-Techne. The key players such as Sartorius AG and Abcam PLC have adopted product launch, acquisition, and partnership as major developmental strategies to improve the product portfolio.
Key Benefits For StakeholdersThis report provides a quantitative analysis of the market segments, current trends, estimations, and dynamics of the protein assays market analysis from 2022 to 2032 to identify the prevailing protein assays market opportunities.
The market research is offered along with information related to key drivers, restraints, and opportunities.
Porter's five forces analysis highlights the potency of buyers and suppliers to enable stakeholders make profit-oriented business decisions and strengthen their supplier-buyer network.
In-depth analysis of the protein assays market segmentation assists to determine the prevailing market opportunities.
Major countries in each region are mapped according to their revenue contribution to the global market.
Market player positioning facilitates benchmarking and provides a clear understanding of the present position of the market players.
The report includes the analysis of the regional as well as global protein assays market trends, key players, market segments, application areas, and market growth strategies.
Key Market SegmentsBy ApplicationDrug Discovery and Development
Disease Diagnosis
By Product TypeKits and Reagents
Instruments and Accessories
By TechnologyAbsorbance Based Protein Assays
Colorimetric based protein assay
Fluorescence-Based Protein Assays
By End UserPharmaceutical and biotechnology companies
Clinical Laboratories
Others
By RegionNorth America
U.S.
Canada
Mexico
Europe
Germany
France
UK
Italy
Spain
Rest of Europe
Asia-Pacific
Japan
China
Australia
India
South Korea
Rest of Asia-Pacific
LAMEA
Brazil
Saudi Arabia
South Africa
Rest of LAMEA
Key Market PlayersAgilent Technologies, Inc.
Perkin Elmer Inc
Abcam Plc
Meril Life Sciences Pvt. Ltd.
Cell Signaling Technology
Sartorius AG
Thermo Fisher Scientific Inc.
Merck KGaA
Bio-Rad Laboratories, Inc.
Bio-Techne
Please Note: It will take 7-10 business days to complete the report upon order confirmation.